Recently, Hongmo Biotech (Shanghai) Co., Ltd., a subsidiary of Mengniu Group, achieved a significant milestone by obtaining the GRAS (Generally Recognized As Safe) certification from the U.S. Food and Drug Administration (FDA) for its independently developed human milk oligosaccharide (HMO) 2’-FL (2’-Fucosyllactose). This certification marks Hongmo Biotech as the first and currently the only Chinese domestic HMO company to receive this recognition. Source: Mengniu Dairy
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE